Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9345753 | Journal Français d'Ophtalmologie | 2005 | 5 Pages |
Abstract
For the first time a triple dose was delivered to the human eye with a single lyophilisate application. Significantly better bioavailability was achieved in the C and AC for up to 7h using this new device. The treatment of glaucoma, bacterial, viral, and fungal infections, as well as dry eye syndrome, for example, will be improved using lyophilisate.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
A. Lux, S. Dinslage, R. Süverkrüp, S. Maier, M. Diestelhorst,